Sylexis Limited is managed by Dr Gillian Pritchard, an experienced pharmaceutical physician with expertise in early and late phase product development in Europe and the USA, to ICH-GCP standards, across several therapeutic areas, e.g. clinical pharmacology, diabetes and cardiovascular medicine, within academia, pharmaceutical, contract research and consultancy companies.

Gillian is a Member of the Faculty of Pharmaceutical Medicine (MFPM) and a Member of the Royal College of Physicians in the UK (MRCP). She has been awarded an MBA from the University of Dundee and a Master of Science (Clinical Pharmacology) from the University of Aberdeen.

Gillian is also a member of BioDundee and of the European Medical Writers Association (EMWA).  Gillian’s roles within EMWA include Treasurer (2009-2011) and leader of the GCP and Drug Safety Workshops.